CEO pay benchmark · Over $200B
Mega-cap Pharmaceutical Preparations CEO salary
The median CEO compensation at mega-cap companies in the pharmaceutical preparations industry is $28,183,748. That is 115% higher than the median across all pharmaceutical preparations companies in our benchmark.
Median CEO pay
$28.2M
Typical range
$21.6M–$32.7M
Companies
6
Average pay ratio
268:1
Vs. full industry
+115%
Size effect
How this group compares with the full industry
The same compensation measures are shown side by side, so the company-size difference is visible without mixing in another dataset.
| Measure | Mega-cap | All Pharmaceutical Preparations |
|---|---|---|
| Companies | 6 | 54 |
| Median CEO pay | $28,183,748 | $13,107,123 |
| Average CEO pay | $25,363,738 | $20,759,020 |
| Middle 50% range | $21.6M–$32.7M | $8.4M–$19.2M |
| Average pay ratio | 268:1 | 150:1 |
Company appendix
Highest CEO pay in this peer group
Up to ten of the highest-paid CEOs in this benchmark, ordered by total annual compensation. Open any company for its full pay breakdown.
| Company | CEO | Total compensation | Market cap |
|---|---|---|---|
| ELI LILLY & CoLLY | David A. Ricks | $36.7M | $1.1T |
| JOHNSON & JOHNSONJNJ | Joaquin Duato | $32.8M | $633.9B |
| AbbVie Inc.ABBV | Robert A. Michael | $32.5M | $438.5B |
| ASTRAZENECA PLCAZN | Pascal Soriot | $23.8M | $266.1B |
| Merck & Co., Inc.MRK | Robert M. Davis | $20.8M | $321.6B |
| BeOne Medicines Ltd.ONC | John V. Oyler | $5.6M | $428.2B |
Nearby peer groups